Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese

Schizophrenia Research

Volumn 119, Issue 1-3, 2010, Pages 273-274

  Ma, Jie ^a   Li, Dong Min ^a   Zhang, Rui ^a   Yang, Xu Dong ^a   Gao, Cheng Ge ^a   Lu, She Min ^a   Wu, Sheng Nan ^c   Wang, Lei ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE CYSTEINE LIGASE;

ADULT; CHINESE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE-CYSTEINE LIGASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 77951487910     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.12.017     Document Type: Letter

References (6)

1. Che R., Tang W., Shao L., Zhao Q., Huang K., Tang R., Li Z., Zhao X., Ji W., Zhou G., Feng G., He L., Shi Y. Association and expression studies of glutamate-cysteine ligase modifier (GCLM) and schizophrenia in the Chinese Han population. Psychiat. Genet 2009, 19(5):279-280.
2. Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Inada T., Harano M., Komiyama T., Hori T., Yamada M., Iyo M., Sora I., Sekine Y., Ozaki N., Ujike H., Iwata N. Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population. Ann. N. Y. Acad. Sci 2008, 1139:63-69.
3. Lavoie S., Chen Y., Dalton T.P., Gysin R., Cuenod M., Steullet P., Do K.Q. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J. Neurochem. 2009, 108(6):1410-1422.
4. Ma J., Qin W., Wang X.Y., Guo T.W., Bian L., Duan S.W., Li X.W., Zou F.G., Fang Y.R., Fang J.X., Feng G.Y., Gu N.F., Clair D.S., He L. Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations. Mol. Psychiatry 2006, 11(5):479-487.
5. Matsuzawa D., Hashimoto K., Hashimoto T., Shimizu E., Watanabe H., Fujita Y., Iyo M. Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population. Am. J. Med. Genet 2008, 150B(1):86-94.
6. Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., Matthey M., Parnas J., Preisig M., Saraga M., Solida A., Timm S., Wang A.G., Werge T., Cuenod M., Do K.Q. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am. J. Hum. Genet 2006, 79(3):586-592.